scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CRAD.2011.08.011 |
P698 | PubMed publication ID | 21920517 |
P50 | author | Joon Seok Lim | Q57611772 |
Yong Eun Chung | Q60656351 | ||
Jin-Young Choi | Q61104180 | ||
Mi-Suk Park | Q73128583 | ||
P2093 | author name string | K-W Kim | |
K-A Kim | |||
M-J Kim | |||
C-K Baek | |||
P433 | issue | 2 | |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
chronic liver disease | Q5113984 | ||
P304 | page(s) | 148-156 | |
P577 | publication date | 2011-09-13 | |
P1433 | published in | Clinical Radiology | Q15754925 |
P1476 | title | Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT | |
P478 | volume | 67 |
Q38059620 | A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. |
Q35858656 | Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis |
Q38219801 | Consensus report from the 6th International forum for liver MRI using gadoxetic acid |
Q89623916 | Controversies in the management of hepatocellular carcinoma |
Q53084289 | Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI. |
Q44481786 | Diagnosis of and therapy for hepatocellular carcinoma |
Q58720455 | Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography |
Q38869595 | Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis |
Q26772319 | Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents? |
Q26799474 | Focal liver lesions: Practical magnetic resonance imaging approach |
Q26798636 | Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis |
Q35203565 | Gadoxetic acid disodium (Gd-EOBDTPA)-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis |
Q34963150 | Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis |
Q36051492 | Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis |
Q60928781 | Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma |
Q38670649 | Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment |
Q64986469 | Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI. |
Q87145592 | Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease? |
Q26797521 | JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan |
Q38827648 | Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 2. |
Q44043742 | Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography |
Q44199365 | Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma |
Q37642297 | The diagnosis and treatment of hepatocellular carcinoma |
Q37530575 | The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma |
Q88189237 | [Guideline compliant diagnostics of hepatocellular carcinoma] |
Q87421151 | [National S3 guidelines on hepatocellular carcinoma] |
Search more.